SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000882104-15-000054
Filing Date
2015-09-08
Accepted
2015-09-08 16:03:16
Documents
2
Period of Report
2015-09-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_144174258550677.html 3  
1 FORM 3 wf-form3_144174258550677.xml 3 1668
2 POWER OF ATTORNEY FOR: /S/ NATHAN N. KRYSZAK, ATTORNEY-IN-FACT FOR PAUL R. EDICK poa.htm EX-24 3631
  Complete submission text file 0000882104-15-000054.txt   6784
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NEWLINK GENETICS CORP. 2503 SOUTH LOOP DR., SUITE 5100 AMES IA 50010
Business Address
Edick Paul R (Reporting) CIK: 0001531178 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19756 | Film No.: 151096892